Related Experiment Videos
Nimodipine: synthesis and metabolic pathway
Arzneimittel-Forschung
|January 1, 1983
Summary
This study details the synthesis and metabolism of nimodipine, a cerebral vasodilator. Researchers identified key metabolites in rats, suggesting ether cleavage and oxidation as primary biotransformation pathways for nimodipine.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Drug Metabolism
Background:
- Nimodipine (Bay e 9736) is a calcium channel blocker used as a cerebral vasodilator.
- Its synthesis involves a crucial cyclizing Michael addition step.
- Understanding nimodipine's metabolism is vital for its therapeutic application.
Purpose of the Study:
- To elucidate the metabolic fate of nimodipine in rats.
- To identify the primary metabolites of nimodipine.
- To propose a metabolic pathway for nimodipine biotransformation.
Main Methods:
- Synthesis of nimodipine and reference metabolites.
- Pharmacokinetic study using 14C-labeled nimodipine in rats.
- Identification and characterization of nimodipine metabolites.
Main Results:
- Major metabolites identified include dihydropyridines (6, 8) and pyridines (7, 9-11, 13-14).
- A potential metabolic pathway involves initial ether cleavage and oxidation to the pyridine form.
- Reference metabolites were successfully synthesized for comparison.
Conclusions:
- Ether cleavage and oxidation are proposed as primary biotransformation steps for nimodipine.
- The identified metabolites provide insight into nimodipine's in vivo processing.
- This research aids in understanding nimodipine's pharmacokinetic profile and potential drug interactions.